表没食子儿茶素没食子酸酯和维生素C联用对高尿酸血症小鼠血尿酸水平的影响

doi:10.13305/j.cnki.jts.2020.03.011

茶叶科学 ›› 2020, Vol. 40 ›› Issue (3): 407-414.doi: 10.13305/j.cnki.jts.2020.03.011

表没食子儿茶素没食子酸酯和维生素C联用对高尿酸血症小鼠血尿酸水平的影响

徐燕^1,2, 蔡吓强^1,2, 解千金^1,2, 邰玲玲^1,2, 刘增辉³

1.茶树生物学与资源利用国家重点实验室,安徽合肥 230036;
2.安徽农业大学茶与食品科技学院,安徽合肥 230036;
3.安徽省医学科学研究院,安徽合肥 230061

收稿日期:2020-01-17 修回日期:2020-02-06 出版日期:2020-06-15 发布日期:2020-06-09
作者简介:徐燕,女,副教授,主要从事茶学和食品科学方面的教学和科研工作,yanxu@ahau.edu.cn
基金资助:
安徽省自然科学基金（1908085MC74）、安徽省重点研究与开发计划项目（202004h07020003）、安徽省茶叶化学与健康领军人才团队引进重大示范项目

The Intergative Effects of Epigallocatechin-3-gallate and Vitamin C on Serum Uric Acid Levels in Hyperuricemic Mice

XU Yan^1,2, CAI Xiaqiang^1,2, XIE Qianjin^1,2, TAI Lingling^1,2, LIU Zenghui³

1. State Key Laboratory of Tea Biology and Utilization, Hefei 230036, China;
2. School of Tea & Food Science and Technology, Anhui Agricultural University, Hefei 230036, China;
3. Anhui Academy of Medical Science, Hefei 230061, China.

Received:2020-01-17 Revised:2020-02-06 Online:2020-06-15 Published:2020-06-09

摘要/Abstract

摘要： 以KM雄性小鼠为研究对象,酵母膏（7.5 g·kg^-1）和氧嗪酸钾（250 mg·kg^-1）联合给药建立高尿酸血症小鼠模型,探究表没食子儿茶素没食子酸酯（EGCG）和维生素C（Vc）联用对高尿酸血症小鼠血尿酸水平的影响。将小鼠随机分为6组（n=6）：空白组、模型组、别嘌呤醇组（阳性药组）、EGCG组、EGCG联合Vc组和Vc组,连续给药7 d后测定生化指标。结果表明,与模型组相比,EGCG联合Vc组小鼠的血尿酸值（UA）,血尿素氮（BUN）和肌酐（Cr）水平均明显降低（P<0.001）;EGCG与Vc联用明显抑制了肝脏中腺苷脱氨酶（ADA）和黄嘌呤氧化酶（XOD）的活性（P<0.05或P<0.01）,并显著下调了肾脏中葡萄糖转运蛋白9（GLUT9）mRNA的表达（P<0.001）;肾脏切片显示EGCG和Vc联用显著改善高尿酸血症小鼠的肾脏损伤。此外,EGCG与Vc联用对高尿酸血症小鼠的作用效果优于EGCG。

关键词: 表没食子儿茶素没食子酸酯, 维生素C, 高尿酸血症, 血尿酸, 葡萄糖转运蛋白9

Abstract: KM male mice were used as subjects of the study. Yeast extracts (7.5 g·kg^-1) and potassium oxonate (250 mg·kg^-1) were administered to establish the hyperuricemic mice model. The study aimed to investigate the integrative effect of EGCG and vitamin C (Vc) on serum uric acid levels of hyperuricemic mice. Mice were randomly divided into 6 groups (n=6): blank group, model group, allopurinol group, EGCG group, EGCG + Vc group and Vc group. The biochemical indexes of mice were measured after 7 d of continuous administration. The results show that the serum uric acid (UA), serum urea nitrogen (BUN) and creatinine (Cr) of EGCG + Vc group were significantly lower than those of the model group (P<0.001). The combination of EGCG and Vc could remarkably inhibited the activities of adenosine deaminase (ADA) and xanthine oxidase (XOD) in the liver (P<0.05 or P<0.01) and significantly down-regulated the expression of glucose transporter 9 (GLUT9) in the kidney (P<0.001). The results of kidney slices indicated that EGCG + Vc could obviously improve the damages to the kidney in hyperuricemic mice. In addition, the integrative effect of EGCG + Vc on hyperuricemic mice was better than that of EGCG.

Key words: EGCG, ascorbic acid, hyperuricemia, serum UA, GLUT9

中图分类号:

徐燕, 蔡吓强, 解千金, 邰玲玲, 刘增辉. 表没食子儿茶素没食子酸酯和维生素C联用对高尿酸血症小鼠血尿酸水平的影响[J]. 茶叶科学, 2020, 40(3): 407-414. doi: 10.13305/j.cnki.jts.2020.03.011.

XU Yan, CAI Xiaqiang, XIE Qianjin, TAI Lingling, LIU Zenghui. The Intergative Effects of Epigallocatechin-3-gallate and Vitamin C on Serum Uric Acid Levels in Hyperuricemic Mice[J]. Journal of Tea Science, 2020, 40(3): 407-414. doi: 10.13305/j.cnki.jts.2020.03.011.

参考文献 16

[1]	Boffetta P, Nordenvall C, Nyrén O, et al.A prospective study of gout and cancer[J]. European Journal of Cancer Prevention, 2009, 18(2): 127-132.
[2]	Mallat S G, Al Kattar S, Tanios B Y, et al.Hyperuricemia, hypertension, and chronic kidney disease: an emerging association[J]. Current Hypertension Reports, 2016, 18(10): 74. doi: 10.1007/s11906-016-0684-z.
[3]	Li M, Hu X L, Fan Y L, et al.Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis[J]. Scientific Reports, 2016, 6: 19520. doi: 10.1038/srep19520.
[4]	Mortada I.Hyperuricemia, type 2 diabetes mellitus, and hypertension: an emerging association[J]. Current Hypertension Reports, 2017, 19(9): 69. doi: 10.1007/s11906-017-0770-x.
[5]	Schlesinger N, Norquist J M, Watson D J.Serum urate during acute gout[J]. Journal of Rheumatology, 2009, 36(6): 1287-1289.
[6]	Nikoo M, Regenstein J M, Gavlighi H A.Antioxidant and antimicrobial activities of (-)-epigallocatechin-3-gallate (EGCG) and its potential to preserve the quality and safety of foods[J]. Comprehensive Reviews in Food Science and Food Safety, 2018, 17(3): 732-753.
[7]	Rady I, Mohamed H, Rady M, et al.Cancer preventive and therapeuticeffects of EGCG, the major polyphenol in green tea[J]. Egyptian Journal of Basic andApplied Sciences, 2018, 5(1): 1-23.
[8]	Eng Q Y, Thanikachalam P V, Ramamurthy S.Molecular understanding of epigallocatechin-gall-ate (EGCG) in cardiovascular and metabolic diseases[J]. Journal of Ethnopharmacology, 2018, 210: 296-310.
[9]	孙陶利, 江妹, 马宁. 表没食子儿茶素没食子酸酯稳定性及稳定化方法研究进展[J]. 转化医学杂志, 2018, 7(6): 377-381.
	Sun T L, Jiang M, Ma N.Progress in research on stability and stabilization of epigallocatechin gallate[J]. Translational Medicine Journal, 2018, 7(6): 377-381.
[10]	李丹, 初阳, 杨倩. 茶多酚在大鼠肠道的吸收动力学研究[J]. 中国医科大学学报, 2014, 43(10): 914-916, 930.
	Li D, Chu Y, Yang Q.Study on absorption kinetics of tea polyphenol in rat intestine[J]. Journal of China Medical University, 2014, 43(10): 914-916, 930.
[11]	徐懿, 屠幼英, 钟小玉. 茶儿茶素异构化研究现状[J]. 中草药, 2008, 39(7): 1106-1109.
	Xu Y, Tu Y Y, Zhong X Y.Review on epimerization of tea catechins[J]. Chinese Traditional and Herbal Drugs, 2008, 39(7): 1106-1109.
[12]	扎米热·库尔班, 孙玉萍, 徐菲莉. GLUT9在尿酸重吸收中的作用及其与相关疾病关联性研究进展[J]. 医学综述, 2018, 24(20): 2983-2987.
	Kurban Z, Sun Y P, Xu F L.Role of GLUT9 in uric acid reabsorption and its association with related diseases[J]. Medical Recapitulate, 2018, 24(20): 3983-3987.
[13]	韩笑. 高尿酸血症的形成机制简述[J]. 临床医药文献电子杂志, 2017, 4(63): 12467.
	Han X.Brife review on the formation mechanism of hyperuricemia[J]. Journal of Clinical Medical, 2017, 4(63): 12467.
[14]	李媛媛, 周海燕, 吴绿英, 等. 大鼠高尿酸血症模型的建立与研究[J]. 中国实验动物学报, 2019, 27(6): 747-752.
	Li Y Y, Zhou H Y, Wu L Y, et al.Establishment and study of a hyperuricemia rat model[J]. Acta Laboratorium Animalis Scientia Sinica, 2019, 27(6): 747-752.
[15]	Zhu C, Xu Y, Liu Z H.The anti-hyperuricemic effect of epigallocatechin-3-gallate (EGCG) on hyperur-icemicmice[J]. Biomedicine & Pharmacotherapy, 2018, 97: 168-173.
[16]	Auberson M, Stadelmann S, Stoudmann C, et al.SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney[J]. Pflügers Archiv-European Journal of Physiology, 2018, 470(12): 1739-1751.

表没食子儿茶素没食子酸酯和维生素C联用对高尿酸血症小鼠血尿酸水平的影响

The Intergative Effects of Epigallocatechin-3-gallate and Vitamin C on Serum Uric Acid Levels in Hyperuricemic Mice

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 16

相关文章 13

Metrics

本文评价

推荐阅读 10

[1]	陈春晓, 楼文雨, 丁镇建, 李卓烨, 杨媛媛, 金鹏, 杜琪珍. 伐地那非增加EGCG-β-乳球蛋白纳米粒对肝癌细胞的抑制作用[J]. 茶叶科学, 2020, 40(4): 528-535.
[2]	袁冬寅, 肖文军, 彭影琦, 林玲, 周阳, 谭春波, 谭洪波, 龚志华. 红茶及其发花红砖茶对高尿酸血症模型小鼠的降尿酸作用[J]. 茶叶科学, 2019, 39(1): 34-42.
[3]	方洪枫, 张慧霞, 王国红, 杨民和. 混菌发酵绿茶产脂肪酶及其对酯型儿茶素的水解作用分析[J]. 茶叶科学, 2019, 39(1): 88-97.
[4]	朱创, 刘增辉, 赵永青, 邰玲玲, 徐燕. 红茶提取物对高尿酸血症小鼠血尿酸的影响[J]. 茶叶科学, 2017, 37(2): 167-172.
[5]	金红娜, 宋烨威, 崔卫波, 谢宏. 儿茶素单体对小鼠急性高尿酸血症的作用[J]. 茶叶科学, 2016, 36(4): 347-353.
[6]	刘洪国. EGCG对肾缺血再灌注损伤的保护作用及其作用机制的研究[J]. 茶叶科学, 2016, 36(2): 169-174.
[7]	黄美蓉, 应浩, 江用文, 江和源, 杜琪珍. EGCG纳米粒的制备及其抗肿瘤活性研究[J]. 茶叶科学, 2015, 35(6): 605-612.
[8]	严煜钧, 刘仲华, 林勇, 黄建安, 彭彬, 蒋华军. 茶叶中EGCG对非酒精性脂肪肝大鼠的调脂保肝作用研究[J]. 茶叶科学, 2014, 34(3): 221-229.
[9]	伍妍俊, 汪小钢, 宛晓春. 甲基化EGCG的研究现状及展望[J]. 茶叶科学, 2010, 30(6): 407-413.
[10]	肖波, 屈慧鸽, 黄清荣, 于川川, 赵波. 茶多酚与维生素C混合抑制幽门螺杆菌的研究[J]. 茶叶科学, 2006, 26(4): 295-298.
[11]	王岳飞, 高永贵, 周雅琴, 杨贤强, 徐春英. 茶与DNA相互作用及维生素C和咖啡因对它的影响[J]. 茶叶科学, 1999, 19(02): 150-154.
[12]	沈生荣, 杨贤强, 赵保路, 忻文娟. 茶多酚体外助氧化作用的自由基机理[J]. 茶叶科学, 1992, 12(02): 145-150.
[13]	沈生荣, 杨贤强, 赵保路, 忻文娟. 茶多酚复合体及(一)——EGCG对氧自由基的清除作用[J]. 茶叶科学, 1992, 12(01): 59-64.